These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 15546884
1. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells. Ling Y, Maile LA, Badley-Clarke J, Clemmons DR. J Biol Chem; 2005 Feb 04; 280(5):3151-8. PubMed ID: 15546884 [Abstract] [Full Text] [Related]
2. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Maile LA, Badley-Clarke J, Clemmons DR. Mol Biol Cell; 2003 Sep 04; 14(9):3519-28. PubMed ID: 12972543 [Abstract] [Full Text] [Related]
3. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Ling Y, Maile LA, Lieskovska J, Badley-Clarke J, Clemmons DR. Mol Biol Cell; 2005 Jul 04; 16(7):3353-64. PubMed ID: 15888547 [Abstract] [Full Text] [Related]
4. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Maile LA, Clemmons DR. Endocrinology; 2002 Nov 04; 143(11):4259-64. PubMed ID: 12399420 [Abstract] [Full Text] [Related]
5. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor. Ling Y, Maile LA, Clemmons DR. Mol Endocrinol; 2003 Sep 04; 17(9):1824-33. PubMed ID: 12791772 [Abstract] [Full Text] [Related]
6. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs. Clemmons DR, Maile LA. Mol Endocrinol; 2005 Jan 04; 19(1):1-11. PubMed ID: 15528274 [Abstract] [Full Text] [Related]
7. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Maile LA, Clemmons DR. Circ Res; 2003 Nov 14; 93(10):925-31. PubMed ID: 14563713 [Abstract] [Full Text] [Related]
8. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. Lieskovska J, Ling Y, Badley-Clarke J, Clemmons DR. J Biol Chem; 2006 Sep 01; 281(35):25041-53. PubMed ID: 16825188 [Abstract] [Full Text] [Related]
9. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR. Mol Endocrinol; 2006 Feb 01; 20(2):405-13. PubMed ID: 16195248 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells. Radhakrishnan Y, Busby WH, Shen X, Maile LA, Clemmons DR. J Biol Chem; 2010 May 21; 285(21):15682-95. PubMed ID: 20207740 [Abstract] [Full Text] [Related]
11. Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons. Araki T, Yamada M, Ohnishi H, Sano S, Uetsuki T, Hatanaka H. J Neurochem; 2000 Feb 21; 74(2):659-68. PubMed ID: 10646517 [Abstract] [Full Text] [Related]
12. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K. J Biol Chem; 2004 Sep 24; 279(39):40807-18. PubMed ID: 15272025 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions. Moralez AM, Maile LA, Clarke J, Busby WH, Clemmons DR. J Cell Physiol; 2005 May 24; 203(2):328-34. PubMed ID: 15700281 [Abstract] [Full Text] [Related]
14. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells. Kwon M, Ling Y, Maile LA, Badley-Clark J, Clemmons DR. Endocrinology; 2006 Mar 24; 147(3):1458-65. PubMed ID: 16306077 [Abstract] [Full Text] [Related]